Ashland reports Q4 fiscal 2026 sales of $498M, up 4%, and issues FY2027 outlook
FROM THE WIRE · GLOBENEWSWIRE.COM
Sales of $498 million, up four percent from the prior-year quarter Loss from continuing operations of $17 million, or ($0.36) per diluted share Adjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $52 million, or $1.12 per diluted share Net…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralResults showing moderate growth and the FY2027 guidance matter to investors in specialty chemicals.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Quarterly sales were $498 million, up 4%.
- 02Adjusted EBITDA was $121 million, up 2%.
- 03For fiscal 2027, sales are expected between $1,905 and $1,975 million.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets